May 7, 2026 07:05AM
Feb 25, 2026 07:05AM
Nov 10, 2025 07:05AM
Aug 7, 2025 07:05AM
May 7, 2025 07:05AM
Feb 27, 2025 07:00AM
Nov 7, 2024 07:00AM Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
Aug 8, 2024 07:00AM
May 9, 2024 07:00AM
Feb 15, 2024 07:00AM
Jan 8, 2024 06:01AM
Jan 8, 2024 06:00AM
Dec 12, 2023 04:01PM
Dec 12, 2023 04:01PM Ironwood Announces the Completion of Squeeze-Out Merger With VectivBio
Nov 9, 2023 07:00AM
Aug 8, 2023 07:00AM
Jun 29, 2023 08:30AM
Jun 16, 2023 07:01AM
Jun 16, 2023 07:00AM
May 22, 2023 06:57AM
May 22, 2023 06:57AM Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
May 4, 2023 07:00AM
Feb 16, 2023 07:00AM
Nov 3, 2022 07:01AM
Aug 4, 2022 07:00AM
May 9, 2022 08:00AM
May 5, 2022 07:00AM
Feb 17, 2022 07:00AM Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2021
Nov 4, 2021 07:15AM
Nov 4, 2021 07:00AM
Nov 4, 2021 07:00AM
Aug 5, 2021 07:00AM
May 6, 2021 07:03AM
May 6, 2021 07:00AM
Feb 17, 2021 07:01AM Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results, Exceeding or Meeting Full Year 2020 Financial Guidance; Provides Full Year 2021 Financial Guidance
Nov 5, 2020 04:03PM
Aug 6, 2020 07:00AM
Feb 13, 2020 07:00AM
Oct 31, 2019 07:00AM
Jul 30, 2019 04:01PM
May 2, 2019 07:00AM
Feb 13, 2019 07:00AM Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2018 Investor Update
Jan 24, 2019 08:00AM
Nov 6, 2018 08:09AM
Aug 6, 2018 08:00AM
May 14, 2018 07:30AM
May 1, 2018 07:55AM
Feb 15, 2018 08:01AM
Nov 2, 2017 08:01AM Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update
Aug 3, 2017 04:01PM

1,157,952 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All